企業プロフィール
Longboard Pharmaceuticals 株価・ニュース・カタリスト
- ティッカー:
- LBPH
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for LBPH.
企業概要
事業概要
Longboard Pharmaceuticals was a neuroscience company focused on epilepsy and neurological disorders before being acquired by Lundbeck. Its story centered on a targeted CNS asset and clinical differentiation.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ prior to acquisition, Longboard sat in specialty neuroscience biotechnology.
ビジネスモデルの特徴
The business depended on clinical data, CNS differentiation, and the strategic value of its pipeline.
バイオ業界での位置付け
Longboard was a focused neuroscience catalyst name and now belongs to biotech M&A history.
今後のカタリスト
- Longboard’s catalyst is bexicaserin in pediatric and rare epilepsies, with dose and efficacy updates doing most of the work. The company is still very much a one-program story.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。